Delivery Order SPE2DB22D3301-SPE2DB25FY2BW
Award Date
3/24/25
Potential Completion Date
3/25/25
Potential Value
$12K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $17,009.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,565,665,266 units of Ondansetron HCL 4 mg tablets, a medication used to prevent nausea and vomiting. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of September 4, 2024. It is not designated as a...
This federal contract award, valued at $16,782.49, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,966,829 units of Ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 21, 2025. AmerisourceBergen Drug Corp holds a significant...
This federal contract award, valued at $15,708.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,567,875,184 units of Ondansetron HCL 4 mg tablets, a medication used to treat nausea and vomiting. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 11, 2025. Amerisourcebergen Drug Corp holds a...
This federal contract award, valued at $22,819.04, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,037,797 units of Ondansetron HCL 4 mg tablets, a medication used to treat nausea and vomiting. The contract type is a Delivery Order with a Firm Fixed Price pricing mechanism and an ultimate completion date of January 27, 2025. This contract award is not...
This federal contract award, valued at $12,914.78, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,718,108 units of Ondansetron HCL 4 mg tablets in 30-count packages. The contract is a Firm Fixed Price Delivery Order with a completion date of December 16, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $12,952.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order for the supply of 4 mg Ondansetron HCL tablets, a medication used to prevent nausea and vomiting. The contract has a firm fixed-price pricing type and an ultimate completion date of February 10, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $10,038.08, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,254,639 units of 4 mg Ondansetron HCL tablets, a medication used to prevent nausea and vomiting. The contract is a Firm Fixed Price Delivery Order with a completion date of February 13, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award, valued at $7,721.18, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,612,620 tablets of Ondansetron HCL 4 mg, a medication used to treat nausea and vomiting. The contract has an ultimate completion date of December 5, 2024 and is a firm fixed-price delivery order. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award, valued at $3,069.22, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,062,083 units of Ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting. This is a firm-fixed-price delivery order contract with an ultimate completion date of April 29, 2025. The contract is not set-aside and is open to competition....
This federal contract award, valued at $11,502.47, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,565,562,970 units of Ondansetron HCL 4 mg tablets, a medication commonly used to treat nausea and vomiting. The contract has a firm fixed price and an ultimate completion date of August 26, 2024. Amerisourcebergen holds a significant...